Polygenic risk scores (PRSs) have shown promise in predicting susceptibility to common
diseases 1 , 2 – 3 . We estimated their added value in clinical risk prediction of five common …

Polygenic risk scores (PRS) measure genetic disease susceptibility by combining risk effects
across the genome. For coronary artery disease (CAD), type 2 diabetes (T2D), and breast …

Population isolates such as those in Finland benefit genetic research because deleterious
alleles are often concentrated on a small number of low-frequency variants (0.1% ≤ minor …

Polygenic risk scores (PRS) for breast cancer have potential to improve risk prediction, but
there is limited information on their utility in various clinical situations. Here we show that …

Background: Prediction tools that combine polygenic risk scores with clinical factors provide
a new opportunity for improved prediction and prevention of atherosclerotic cardiovascular …

Population isolates such as Finland provide benefits in genetic studies because the allelic
spectrum of damaging alleles in any gene is often concentrated on a small number of low-…

Clinical laboratory tests are a critical component of the continuum of care. We evaluate the
genetic basis of 35 blood and urine laboratory measurements in the UK Biobank (n = 363,228 …

There is currently limited understanding of the genetic aetiology of obstructive sleep apnoea
(OSA). We aimed to identify genetic loci associated with OSA risk, and to test if OSA and its …

Although genetic risk scores have been used to predict hypertension, their utility in the
clinical setting remains uncertain. Our study comprised N=218 792 FinnGen participants (mean …

Importance A genetic contribution to preeclampsia susceptibility has been established but is
still incompletely understood. Objective To disentangle the underlying genetic architecture …